These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 17879942)
1. Signaling of DNA damage is not sufficient to induce p53 response: (re)activation of wt p53 protein strongly depends on cellular context. Wesierska-Gadek J; Gueorguieva M; Komina O; Schmid G; Kramer MP J Cell Biochem; 2008 Apr; 103(5):1607-20. PubMed ID: 17879942 [TBL] [Abstract][Full Text] [Related]
2. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942 [TBL] [Abstract][Full Text] [Related]
3. Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Wesierska-Gadek J; Gueorguieva M; Schloffer D; Uhl M; Wojciechowski J J Cell Biochem; 2003 Aug; 89(6):1222-34. PubMed ID: 12898520 [TBL] [Abstract][Full Text] [Related]
4. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases. Vidal B; Parra M; Jardí M; Saito S; Appella E; Muñoz-Cánoves P Thromb Haemost; 2005 Mar; 93(3):584-91. PubMed ID: 15735814 [TBL] [Abstract][Full Text] [Related]
5. ATM activation by a sulfhydryl-reactive inflammatory cyclopentenone prostaglandin. Kobayashi M; Ono H; Mihara K; Tauchi H; Komatsu K; Shibata T; Shimizu H; Uchida K; Yamamoto K Genes Cells; 2006 Jul; 11(7):779-89. PubMed ID: 16824197 [TBL] [Abstract][Full Text] [Related]
6. The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX. Ye R; Goodarzi AA; Kurz EU; Saito S; Higashimoto Y; Lavin MF; Appella E; Anderson CW; Lees-Miller SP DNA Repair (Amst); 2004 Mar; 3(3):235-44. PubMed ID: 15177039 [TBL] [Abstract][Full Text] [Related]
7. The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways. Kim WJ; Beardsley DI; Adamson AW; Brown KD Toxicol Appl Pharmacol; 2005 Jan; 202(1):84-98. PubMed ID: 15589979 [TBL] [Abstract][Full Text] [Related]
8. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells. Ruiz-Ruiz MC; López-Rivas A Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines. Mantovani F; Banks L Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351 [TBL] [Abstract][Full Text] [Related]
10. Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells. Wesierska-Gadek J; Wandl S; Kramer MP; Pickem C; Krystof V; Hajek SB J Cell Biochem; 2008 Dec; 105(5):1161-71. PubMed ID: 18846503 [TBL] [Abstract][Full Text] [Related]
11. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53. Vikhanskaya F; Erba E; D'Incalci M; Broggini M Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs. Koivusalo R; Krausz E; Helenius H; Hietanen S Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516 [TBL] [Abstract][Full Text] [Related]
13. Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Incassati A; Patel D; McCance DJ Oncogene; 2006 Apr; 25(17):2444-51. PubMed ID: 16369493 [TBL] [Abstract][Full Text] [Related]
14. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. Yoshida M; Shiojima I; Ikeda H; Komuro I J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469 [TBL] [Abstract][Full Text] [Related]
15. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced apoptosis in human cells with normal p53 status and function, without any alteration in the nuclear protein level. Amellem O; Stokke T; Sandvik JA; Smedshammer L; Pettersen EO Exp Cell Res; 1997 May; 232(2):361-70. PubMed ID: 9168813 [TBL] [Abstract][Full Text] [Related]
17. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2. Kool J; Hamdi M; Cornelissen-Steijger P; van der Eb AJ; Terleth C; van Dam H Oncogene; 2003 Jul; 22(27):4235-42. PubMed ID: 12833146 [TBL] [Abstract][Full Text] [Related]
18. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells. Bañuelos A; Reyes E; Ocadiz R; Alvarez E; Moreno M; Monroy A; Gariglio P J Pharmacol Exp Ther; 2003 Aug; 306(2):671-80. PubMed ID: 12750435 [TBL] [Abstract][Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
20. The effects of NBS1 knockdown by small interfering RNA on the ionizing radiation-induced apoptosis in human lymphoblastoid cells with different p53 status. Zhang Y; Lim CU; Zhou J; Liber HH Toxicol Lett; 2007 Jun; 171(1-2):50-9. PubMed ID: 17537595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]